Welcome to our dedicated page for ECOLAB SEC filings (Ticker: ECL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ecolab Inc. filings document the public-company disclosures of a Delaware operating company whose common stock trades on the New York Stock Exchange under ECL. The filings cover operating and financial results, supplemental segment reporting, changes to reportable segment structure, capital-structure information and material-event reports.
Proxy and 8-K filings describe annual-meeting matters, board and executive-leadership changes, compensation and governance topics, and shareholder voting materials. Other disclosures address material agreements, restructuring and exit-cost matters associated with the One Ecolab initiative, business context for water, hygiene and infection prevention operations, and the company’s service footprint across multiple customer industries.
ECOLAB INC. officer Gregory B. Cook, Co-COO – Global Businesses, reported an open-market sale of 4,567.424 shares of Common Stock on August 11, 2026 at a weighted average price of $285.128 per share, with individual trades executed between $285.1277 and $285.265. After this sale, Cook directly holds 11,673.394 shares. In addition, he has an indirect interest through 3,624.511 UNITS in the Ecolab Stock Fund of the Ecolab Savings Plan, which are stated as the equivalent of approximately 6,650 shares of Common Stock.
A shareholder of ECL plans to sell up to 4,567 shares of common stock through Morgan Stanley Smith Barney LLC – Executive Services on the NYSE, with the proposed trade date listed as 08/11/2026. The filing also notes 8,396 shares of common stock underlying Restricted Stock Units scheduled to vest on 05/04/2026 as employee compensation from the issuer.
Ecolab Inc. executive Bryce L. Mewhorter, SVP & Corporate Controller, reports his initial equity holdings. He holds employee stock options on Common Stock with exercise prices between $148.4950 and $268.5150, 2,948 restricted stock units, 1,450.0890 directly held Common shares, and Ecolab Savings Plan units equivalent to approximately 537 shares.
An affiliate of ECL submitted a notice of proposed sale of common stock. The filing lists Morgan Stanley Smith Barney LLC - Executive Services as broker for a planned sale of 1,765 shares of common stock on or after August 7, 2026 on the NYSE. It also discloses that 6,457 shares of common stock became deliverable from restricted stock unit vesting on August 3, 2026, characterized as employee compensation within the past three months.
Ecolab Inc. reported higher second‑quarter 2026 results, with net sales of $4,415.4 million and net income attributable to Ecolab of $534.9 million, compared with $4,025.2 million and $524.2 million a year earlier. Operating income rose to $757.9 million and diluted EPS to $1.90.
For the first six months of 2026, net sales were $8,481.5 million and net income attributable to Ecolab was $967.5 million, with diluted EPS of $3.42. Cash provided by operating activities increased to $1,175.4 million, while capital expenditures rose to $588.6 million.
Ecolab significantly expanded its balance sheet, issuing $5.0 billion of new senior notes (three‑, five‑, seven‑ and ten‑year maturities) primarily to fund the $4.75 billion CoolIT Systems acquisition and for general corporate purposes, lifting total long‑term debt including current maturities to $13,170.8 million and cash to $5,135.3 million as of June 30, 2026. The company continued its One Ecolab restructuring initiative, with cumulative restructuring charges of $250.2 million and special charges of $65.0 million recorded under the program and a remaining restructuring liability of $83.4 million.
ECOLAB INC. executive Jennifer J. Bradway, SVP & Corporate Controller, reported the vesting of 6,457 restricted stock units granted on August 3, 2022. On August 3, 2026 these units converted into an equal number of common shares on a one-for-one basis. To satisfy tax obligations, 2,944.392 shares of common stock were withheld at $278.79 per share under Rule 16b-3, with the remaining shares delivered to her direct holdings. A portion of her direct position, 32.363 shares, arises from automatic dividend reinvestment.
Ecolab Inc. chief financial officer Scott D. Kirkland exercised employee stock options for 3,972 shares of common stock at $117.73 per share, then sold 3,357 shares in a sale in open market or private transaction at $276.96 per share. He also reported indirect ownership of 1,477.401 units in the Ecolab Stock Fund of the Ecolab Savings Plan as of June 30, 2026, equivalent to approximately 2,710 shares of common stock and including 21.817 units acquired since his prior report.
ECL reports a planned disposition of common stock through Morgan Stanley Smith Barney LLC – Executive Services, with trading on the NYSE referenced for 07/30/2026. The transaction is described as a broker-assisted cashless exercise connected to an employee stock option exercise on the same date.
Disclosed figures in the filing include 3,357, 3,972, and 281,437,502, which relate to the common stock and option activity associated with this planned transaction.
Ecolab Inc. reported strong second‑quarter 2026 results, with net sales of $4,415.4 million, up 10% from $4,025.2 million in 2025, and organic sales growth accelerating to 5%. Reported operating income rose 7% to $757.9 million and adjusted operating income increased 10% to $809.0 million. Reported diluted EPS was $1.90, while adjusted diluted EPS was $2.09, 11% above $1.89 a year earlier.
Performance was broad-based: at fixed currency, Global Water sales grew 10%, Global Institutional & Specialty 4%, Global Pest Elimination 9% and Global Life Sciences 15%, with Life Sciences achieving a 26.5% operating margin. Reported gross margin was 44.1% and organic gross margin 44.9% as stronger pricing and productivity offset higher commodity costs and growth investments. Ecolab Digital sales increased 27% to $121 million. Cash from operating activities for the first half of 2026 was $1,175.4 million, and net debt to adjusted EBITDA was 1.9; the company repurchased about 1.2 million shares in the quarter.
Looking ahead, Ecolab raised its full‑year 2026 adjusted diluted EPS outlook to $8.05–$8.25, implying 7%–10% growth versus last year, and guided third‑quarter adjusted EPS to $2.13–$2.23. Management expects second‑half reported sales to increase 12%–14%, organic sales to grow 6%–7% and adjusted and organic operating income margins of about 19% and 20%, respectively, supported by pricing, acquisitions such as Ovivo Electronics and CoolIT, and continued expansion of its Global High‑Tech and Life Sciences growth engines.
JPMorgan Chase & Co. reports beneficial ownership of 14,448,038 shares of Ecolab Inc. common stock, representing 5.1% of the class.
The firm has sole voting power over 13,045,413 shares and shared voting power over 156,195 shares. It holds sole dispositive power over 14,364,448 shares and shared dispositive power over 82,687 shares, with positions held through multiple JPMorgan subsidiaries.